Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians (original) (raw)

Abstract

We have examined cross-clade HIV-specific cytotoxic T-lymphocyte (CTL) activity in peripheral blood of eight Zambian individuals infected with non-B-clade human immunodeficiency virus type 1 (HIV-1). Heteroduplex mobility assay and partial sequence analysis of env and gag genes strongly suggests that all the HIV-infected subjects were infected with clade C HIV-1. Six of eight C-clade HIV-infected individuals elicited CTL activity specific for recombinant vaccinia virus-infected autologous targets expressing HIV gag-pol-env derived from B-clade HIV-1 (IIIB). Recognition of individual recombinant HIV-1 B-clade vaccinia virus-infected targets expressing gag, pol, or env was variable among the patients tested, indicating that cross-clade CTL activity is not limited to a single HIV protein. These data demonstrate that HIV clade C-infected individuals can mount vigorous HIV clade B-reactive CTL responses.

Full Text

The Full Text of this article is available as a PDF (425.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carr J. K., Salminen M. O., Koch C., Gotte D., Artenstein A. W., Hegerich P. A., St Louis D., Burke D. S., McCutchan F. E. Full-length sequence and mosaic structure of a human immunodeficiency virus type 1 isolate from Thailand. J Virol. 1996 Sep;70(9):5935–5943. doi: 10.1128/jvi.70.9.5935-5943.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cornelissen M., Kampinga G., Zorgdrager F., Goudsmit J. Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization. J Virol. 1996 Nov;70(11):8209–8212. doi: 10.1128/jvi.70.11.8209-8212.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Delwart E. L., Shpaer E. G., Louwagie J., McCutchan F. E., Grez M., Rübsamen-Waigmann H., Mullins J. I. Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. Science. 1993 Nov 19;262(5137):1257–1261. doi: 10.1126/science.8235655. [DOI] [PubMed] [Google Scholar]
  4. Fernandez M. H., Fidler S. J., Pitman R. J., Weber J. N., Rees A. D. CD4+ T-cell recognition of diverse clade B HIV-1 isolates. AIDS. 1997 Mar;11(3):281–288. doi: 10.1097/00002030-199703110-00004. [DOI] [PubMed] [Google Scholar]
  5. Ferrari G., Humphrey W., McElrath M. J., Excler J. L., Duliege A. M., Clements M. L., Corey L. C., Bolognesi D. P., Weinhold K. J. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396–1401. doi: 10.1073/pnas.94.4.1396. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Gao F., Robertson D. L., Morrison S. G., Hui H., Craig S., Decker J., Fultz P. N., Girard M., Shaw G. M., Hahn B. H. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol. 1996 Oct;70(10):7013–7029. doi: 10.1128/jvi.70.10.7013-7029.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Higgins D. G., Sharp P. M. Fast and sensitive multiple sequence alignments on a microcomputer. Comput Appl Biosci. 1989 Apr;5(2):151–153. doi: 10.1093/bioinformatics/5.2.151. [DOI] [PubMed] [Google Scholar]
  8. Huang X. L., Fan Z., Liebmann J., Rinaldo C. Detection of human immunodeficiency virus type 1-specific memory cytotoxic T lymphocytes in freshly donated and frozen-thawed peripheral blood mononuclear cells. Clin Diagn Lab Immunol. 1995 Nov;2(6):678–684. doi: 10.1128/cdli.2.6.678-684.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980 Dec;16(2):111–120. doi: 10.1007/BF01731581. [DOI] [PubMed] [Google Scholar]
  10. Louwagie J., Janssens W., Mascola J., Heyndrickx L., Hegerich P., van der Groen G., McCutchan F. E., Burke D. S. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J Virol. 1995 Jan;69(1):263–271. doi: 10.1128/jvi.69.1.263-271.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Louwagie J., McCutchan F. E., Peeters M., Brennan T. P., Sanders-Buell E., Eddy G. A., van der Groen G., Fransen K., Gershy-Damet G. M., Deleys R. Phylogenetic analysis of gag genes from 70 international HIV-1 isolates provides evidence for multiple genotypes. AIDS. 1993 Jun;7(6):769–780. doi: 10.1097/00002030-199306000-00003. [DOI] [PubMed] [Google Scholar]
  12. Lubaki M. N., Egan M. A., Siliciano R. F., Weinhold K. J., Bollinger R. C. A novel method for detection and ex vivo expansion of HIV type 1-specific cytolytic T lymphocytes. AIDS Res Hum Retroviruses. 1994 Nov;10(11):1427–1431. doi: 10.1089/aid.1994.10.1427. [DOI] [PubMed] [Google Scholar]
  13. Mascola J. R., Louwagie J., McCutchan F. E., Fischer C. L., Hegerich P. A., Wagner K. F., Fowler A. K., McNeil J. G., Burke D. S. Two antigenically distinct subtypes of human immunodeficiency virus type 1: viral genotype predicts neutralization serotype. J Infect Dis. 1994 Jan;169(1):48–54. doi: 10.1093/infdis/169.1.48. [DOI] [PubMed] [Google Scholar]
  14. McCutchan F. E., Artenstein A. W., Sanders-Buell E., Salminen M. O., Carr J. K., Mascola J. R., Yu X. F., Nelson K. E., Khamboonruang C., Schmitt D. Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E from Asia and Africa. J Virol. 1996 Jun;70(6):3331–3338. doi: 10.1128/jvi.70.6.3331-3338.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. McKenna S. L., Muyinda G. K., Roth D., Mwali M., Ng'andu N., Myrick A., Luo C., Priddy F. H., Hall V. M., von Lieven A. A. Rapid HIV testing and counseling for voluntary testing centers in Africa. AIDS. 1997 Sep;11 (Suppl 1):S103–S110. [PubMed] [Google Scholar]
  16. Moore J. P., Cao Y., Leu J., Qin L., Korber B., Ho D. D. Inter- and intraclade neutralization of human immunodeficiency virus type 1: genetic clades do not correspond to neutralization serotypes but partially correspond to gp120 antigenic serotypes. J Virol. 1996 Jan;70(1):427–444. doi: 10.1128/jvi.70.1.427-444.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moore J. P., McCutchan F. E., Poon S. W., Mascola J., Liu J., Cao Y., Ho D. D. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J Virol. 1994 Dec;68(12):8350–8364. doi: 10.1128/jvi.68.12.8350-8364.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Nehete P. N., Johnson P. C., Schapiro S. J., Arlinghaus R. B., Sastry K. J. Cross-reactive T-cell proliferative responses to V3 peptides corresponding to different geographical HIV-1 isolates in HIV-seropositive individuals. J Clin Immunol. 1996 Mar;16(2):115–124. doi: 10.1007/BF01540958. [DOI] [PubMed] [Google Scholar]
  19. Pogue R. R., Eron J., Frelinger J. A., Matsui M. Amino-terminal alteration of the HLA-A*0201-restricted human immunodeficiency virus pol peptide increases complex stability and in vitro immunogenicity. Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8166–8170. doi: 10.1073/pnas.92.18.8166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Porter K. R., Mascola J. R., Hupudio H., Ewing D., VanCott T. C., Anthony R. L., Corwin A. L., Widodo S., Ertono S., McCutchan F. E. Genetic, antigenic and serologic characterization of human immunodeficiency virus type 1 from Indonesia. J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Jan 1;14(1):1–6. doi: 10.1097/00042560-199701010-00001. [DOI] [PubMed] [Google Scholar]
  21. Robertson D. L., Hahn B. H., Sharp P. M. Recombination in AIDS viruses. J Mol Evol. 1995 Mar;40(3):249–259. doi: 10.1007/BF00163230. [DOI] [PubMed] [Google Scholar]
  22. Saitou N., Nei M. The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol. 1987 Jul;4(4):406–425. doi: 10.1093/oxfordjournals.molbev.a040454. [DOI] [PubMed] [Google Scholar]
  23. Salminen M. O., Johansson B., Sönnerborg A., Ayehunie S., Gotte D., Leinikki P., Burke D. S., McCutchan F. E. Full-length sequence of an ethiopian human immunodeficiency virus type 1 (HIV-1) isolate of genetic subtype C. AIDS Res Hum Retroviruses. 1996 Sep 20;12(14):1329–1339. doi: 10.1089/aid.1996.12.1329. [DOI] [PubMed] [Google Scholar]
  24. Sette A., Vitiello A., Reherman B., Fowler P., Nayersina R., Kast W. M., Melief C. J., Oseroff C., Yuan L., Ruppert J. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J Immunol. 1994 Dec 15;153(12):5586–5592. [PubMed] [Google Scholar]
  25. Trkola A., Pomales A. B., Yuan H., Korber B., Maddon P. J., Allaway G. P., Katinger H., Barbas C. F., 3rd, Burton D. R., Ho D. D. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J Virol. 1995 Nov;69(11):6609–6617. doi: 10.1128/jvi.69.11.6609-6617.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Trkola A., Purtscher M., Muster T., Ballaun C., Buchacher A., Sullivan N., Srinivasan K., Sodroski J., Moore J. P., Katinger H. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1. J Virol. 1996 Feb;70(2):1100–1108. doi: 10.1128/jvi.70.2.1100-1108.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Wilson C. C., Kalams S. A., Wilkes B. M., Ruhl D. J., Gao F., Hahn B. H., Hanson I. C., Luzuriaga K., Wolinsky S., Koup R. Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J Virol. 1997 Feb;71(2):1256–1264. doi: 10.1128/jvi.71.2.1256-1264.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]